Aquestive insider plans sale of 50,000 shares

Aquestive Therapeutics, Inc. (AQST) is the issuer for which Daniel Barber has filed a Form 144 notice to sell up to 50,000 shares of common stock under Rule 144 through Morgan Stanley Smith Barney LLC on or after September 15, 2026.

Rhea-AI Filing Summary

Aquestive Therapeutics, Inc. (AQST) is the issuer for which Daniel Barber has filed a Form 144 notice to sell up to 50,000 shares of common stock under Rule 144 through Morgan Stanley Smith Barney LLC on or after September 15, 2026. The shares relate to restricted stock units that vested during the period from March 7, 2026 through March 9, 2026. The notice reports an aggregate market value for the planned sale of $244,000 and notes that 125,511,648 shares of common stock are outstanding, with the stock listed on NASDAQ.

The filing also lists prior sales during the past three months under a Rule 10b5-1 trading plan, including 25,000 shares of common stock sold on August 17, 2026 for $107,167.50, 20,369 shares sold on July 16, 2026 for $81,508.59, and 4,631 shares sold on July 15, 2026 for $18,683.50.

Key Figures

Shares to be sold under Rule 144: 50,000 shares Aggregate market value of planned sale: $244,000 Shares outstanding: 125,511,648 shares +4 more

7 metrics

Shares to be sold under Rule 144 50,000 shares Maximum number of AQST common shares in the planned Form 144 sale

Aggregate market value of planned sale $244,000 Reported aggregate market value for the 50,000 AQST shares to be sold

Shares outstanding 125,511,648 shares AQST common shares outstanding as referenced in the Form 144

Shares sold on August 17, 2026 25,000 shares Rule 10b5-1 sale of AQST common stock by Daniel Barber for $107,167.50

Proceeds on August 17, 2026 sale $107,167.50 Consideration received for 25,000 AQST shares sold under a 10b5-1 plan

Shares sold on July 16, 2026 20,369 shares Rule 10b5-1 sale of AQST common stock for $81,508.59

Shares sold on July 15, 2026 4,631 shares Rule 10b5-1 sale of AQST common stock for $18,683.50

Key Terms

Rule 144, restricted stock units, 10b5-1, aggregate market value

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock units financial

"The securities to be sold were acquired upon the vesting of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

10b5-1 regulatory

"10b5-1 Sales for DANIEL BARBER 30 Technology Drive Warren NJ 07059"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

aggregate market value financial

"| 50000 | 244000.00 | 125511648 | 09/15/2026 | NASDAQ"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose about Aquestive Therapeutics, Inc. (AQST)?

The Form 144 reports that an affiliate, Daniel Barber, plans to sell up to 50,000 shares of AQST common stock under Rule 144. The shares were acquired from vested restricted stock units, and the stock is listed on NASDAQ with 125,511,648 shares outstanding.

How many AQST shares is Daniel Barber seeking to sell under Rule 144?

Daniel Barber has noticed the proposed sale of up to 50,000 shares of Aquestive Therapeutics common stock under Rule 144, with an indicated aggregate market value of $244,000 at the time of the notice.

What is the reported aggregate market value of the AQST shares to be sold?

The Form 144 states an aggregate market value of $244,000 for the planned sale of 50,000 AQST common shares under Rule 144, using the market information available as of the notice date.

How many AQST shares are outstanding according to this Form 144?

The notice reports that 125,511,648 shares of Aquestive Therapeutics common stock are outstanding as referenced in the Form 144 securities information section.

What prior AQST share sales by Daniel Barber are disclosed for the past three months?

The filing lists prior Rule 10b5-1 sales: 25,000 shares on August 17, 2026 for $107,167.50, 20,369 shares on July 16, 2026 for $81,508.59, and 4,631 shares on July 15, 2026 for $18,683.50.

How were the AQST shares to be sold acquired by Daniel Barber?

The Form 144 explains that the securities to be sold were acquired upon the vesting of restricted stock units from the issuer during the period from March 7, 2026 through March 9, 2026.

Which broker is handling the planned AQST Form 144 sale for Daniel Barber?

The notice identifies Morgan Stanley Smith Barney LLC Executive Financial Services at 1 New York Plaza, New York, as the broker for the planned Rule 144 sale of 50,000 AQST common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/15/2026 - 04:49 PM Accepted by SEC EDGAR 09/15/2026 - 04:48 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001742266
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Aquestive Therapeutics, Inc.
SEC File Number	001-38599
Address of Issuer	30 Technology Drive Warren NEW JERSEY 07059
Phone	9089411900
Name of Person for Whose Account the Securities are To Be Sold	Daniel Barber
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	50000	244000.00	125511648	09/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/07/2026	Restricted Stock Units	Issuer			50000	03/07/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for DANIEL BARBER 30 Technology Drive Warren NJ 07059	Common	08/17/2026	25000	107167.50
10b5-1 Sales for DANIEL BARBER 30 Technology Drive Warren NJ 07059	Common	07/16/2026	20369	81508.59
10b5-1 Sales for DANIEL BARBER 30 Technology Drive Warren NJ 07059	Common	07/15/2026	4631	18683.50

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 03/07/2026 through 03/09/2026.
Date of Notice	09/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/15/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel R Barber
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)